<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/003812CD-18CA-4415-85A0-D112873B652B"><gtr:id>003812CD-18CA-4415-85A0-D112873B652B</gtr:id><gtr:name>Dundee Signal Transduction Therapy (DSTT) Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EB4EED18-4D2E-4BF5-B732-A731B1DC6C51"><gtr:id>EB4EED18-4D2E-4BF5-B732-A731B1DC6C51</gtr:id><gtr:name>MRC Protein Phosphorylation Unit</gtr:name><gtr:address><gtr:line1>Department of Biochemistry</gtr:line1><gtr:line2>The University of Dundee</gtr:line2><gtr:line3>MSI/WTB Complex</gtr:line3><gtr:postCode>DD1 5EH</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EB4EED18-4D2E-4BF5-B732-A731B1DC6C51"><gtr:id>EB4EED18-4D2E-4BF5-B732-A731B1DC6C51</gtr:id><gtr:name>MRC Protein Phosphorylation Unit</gtr:name><gtr:address><gtr:line1>Department of Biochemistry</gtr:line1><gtr:line2>The University of Dundee</gtr:line2><gtr:line3>MSI/WTB Complex</gtr:line3><gtr:postCode>DD1 5EH</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/003812CD-18CA-4415-85A0-D112873B652B"><gtr:id>003812CD-18CA-4415-85A0-D112873B652B</gtr:id><gtr:name>Dundee Signal Transduction Therapy (DSTT) Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FAE83237-8DDB-4D47-AA54-3EABD118D8D8"><gtr:id>FAE83237-8DDB-4D47-AA54-3EABD118D8D8</gtr:id><gtr:firstName>Carol</gtr:firstName><gtr:surname>MacKintosh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127084354"><gtr:id>B2BBB8CA-CFD6-4381-9415-64928358DF71</gtr:id><gtr:title>The role of 14-3-3 proteins in cellular responses to growth factors and nutrients</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127084354</gtr:grantReference><gtr:abstractText>We have discovered that when human cells are stimulated with insulin, and drugs that mimic the effects of exercise, the result is that distinct but overlapping sets of proteins inside the cells are modified, such that they become recognized and captured by C-shaped proteins called 14-3-3s. The 14-3-3s cuddle and squeeze their captured proteins, which leads to changes in glucose uptake and other processes. One aim is to help explain how insulin and exercise control many processes in our bodies, and provide biomarkers to track changes caused by diabetes and obesity. We also found that many proteins latch onto 14-3-3s when human cells are exposed to growth factors. Growth factors are hormones that activate our cells to absorb nutrients, grow, divide and move, and cancer cells have overactivated responses to growth factors. Our biochemical analyses therefore provide the fundamental underpinnings that will lead to better ways to monitor peoples health status, prevent type II diabetes, and develop and test new drugs to treat cancers and other diseases.</gtr:abstractText><gtr:technicalSummary>How a few intracellular signalling pathways, including PI 3-kinase/PKB, MAPK/p90RSK and AMPK, stimulate wide-ranging changes in cellular behaviours is a fascinating problem, made all the more pressing because these pathways are deregulated in diabetes and cancers, while AMPK mediates beneficial responses to exercise and the anti-diabetic drug metformin. Using 14-3-3 capture and release, combined with differential proteomics, we are discovering how the PI 3-kinase/PKB, MAPK/p90RSK, and AMPK signalling pathways stimulate the phosphorylation and binding to 14-3-3s of large, overlapping subsets of proteins. For example, the Rab GTPase activating protein AS160 is phosphorylated and binds to 14-3-3s in response to insulin, while the related TBC1D1 binds to 14-3-3s in response to AMPK activators. Our biochemical and transgenic mouse experiments suggest that the relative sensitivity of glucose uptake to insulin and/or exercise in different tissues may reflect the different tissue distributions of AS160 and TBC1D1. Biochemical dissection of other target proteins is revealing new mechanisms to explain how insulin, growth factors and nutrients regulate vesicle trafficking, signalling, mitochondrial biogenesis and gene expression. One exciting new project stems from the discovery that EGF stimulates the MAPK/p90RSK-mediated phosphorylation and 14-3-3-binding of multiple components of a transcriptional network implicated in spinocerebellar ataxias, dopaminergic disorders and Ewings family sarcomas. These findings suggest a new hypothesis about how altered growth factor control of neural crest differentiation might contribute to these diseases, and suggest 14-3-3s as therapeutic targets for tumours. Another ambitious goal of our 14-3-3-phosphoproteomics approaches is to identify a core list of proteins that have distinctive signalling signatures and whose 14-3-3-binding status could be used as biomarkers to report on which signalling pathways are active in healthy and disease tissues, and how they respond to drugs.</gtr:technicalSummary><gtr:fund><gtr:end>2013-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3712734</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dundee Signal Transduction Therapy (DSTT) Consortium</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Division of Signal Transduction Therapy</gtr:description><gtr:id>69AF46E1-E9D4-4834-A59C-7078954CD105</gtr:id><gtr:impact>Specific collaborative projects with three of the consortium companies are underway.</gtr:impact><gtr:outcomeId>E310C03D319-1</gtr:outcomeId><gtr:partnerContribution>Discussion, research reagents.</gtr:partnerContribution><gtr:piContribution>My group actively participates in this collaboration involving the University of Dundee, MRC Protein Phosphorylation Unit, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck-Serono and Pfizer. My particular contribution involves using 14-3-3s to capture the signatures that indicate which intracellular signalling pathways are activated in response to hormones, drugs and in disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Public Health Nutrition Research</gtr:department><gtr:description>microscopic imaging of subcellular location of capicua</gtr:description><gtr:id>0AACA98D-AEA4-48C5-BA88-35E7FB8C02EA</gtr:id><gtr:impact>Contriubution to publication PMID: 21087211</gtr:impact><gtr:outcomeId>Gm8UNRbug25-1</gtr:outcomeId><gtr:partnerContribution>Microscipy contriubution to publication PMID: 21087211</gtr:partnerContribution><gtr:piContribution>Biochemical and cellular analyses</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biochemistry Bristol</gtr:department><gtr:description>Activation of phosphodiesterase 3A in human platelets</gtr:description><gtr:id>068CBE9B-B938-4648-95C0-068081DB1918</gtr:id><gtr:impact>19261611</gtr:impact><gtr:outcomeId>8B9A8610F17-1</gtr:outcomeId><gtr:partnerContribution>Expertise in human platelets, to test a hypothesis about the mechanism of activation of platelets that stemmed from our earlier study in cultured human HeLa cells.</gtr:partnerContribution><gtr:piContribution>We contributed the hypothesis under test, specialised reagents including phospho-specific antibodies, and experimental data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biology</gtr:department><gtr:description>vertebrate evolution</gtr:description><gtr:id>70105D3F-CD05-4A02-A73D-E82CF5009DA7</gtr:id><gtr:impact>A paper entitled 'Co-evolution of 14-3-3--binding 2R-ohnologs and vertebrate diseases' is being prepared.</gtr:impact><gtr:outcomeId>c9w7GptF5q8-1</gtr:outcomeId><gtr:partnerContribution>Collaborator has provided background information, and is checking our analyses of the evolutionary history of 14-3-3-binding protein families.</gtr:partnerContribution><gtr:piContribution>We have performed bioinformatic, evolutionary, and biochemical analyses of human 14-3-3-binding proteins from human cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Edinburgh International Science Festival 2010</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>5E5F1CCC-0104-4ABB-85A4-3E1BE1F755C2</gtr:id><gtr:impact>More than 1200 people visited, and feedback by questionnaires was all in the top two categories of enjoyed a lot and a great deal.

Unknown</gtr:impact><gtr:outcomeId>D8PZyozAKso</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh International Science Festival 2009</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>BEC1BEA4-E585-499F-BD26-20EC7D01DB76</gtr:id><gtr:impact>Interactive display and models showing how a protein kinase inhibitor (Gleevec) works to block Bcr-Abl and cure a cancer.

One student who helped demonstrate on this display has used the same activity on other occasions, and has been nominated for a local Public Understanding of Science award.</gtr:impact><gtr:outcomeId>1BE5C0D4E1A</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dundee Science Festival 2010</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>DF9F20F2-370A-49ED-8106-4299ACC4469A</gtr:id><gtr:impact>Around 1400 people attended, and our Cell Signalling activities were kept busy all day, with active participation and discussion with children and adults

Feedback was very positive.</gtr:impact><gtr:outcomeId>Xy6UWkjyjFi</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diabetes UK group 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>87B41C07-911F-48BB-BB60-0E3C9B3899AC</gtr:id><gtr:impact>Gave a lay lecture on my research on regulation of sugar metabolism entitled &amp;quot;Cuddle and squeeze with 14-3-3s&amp;quot;

Contributes to maintaining close links between clinicians/researchers and patients at Ninewells Hospital, and laboratory researchers in the MRC Protein Phosphorylation Unit, and helps fundraising, patient recruitment to research projects, and general awareness about diabetes within Dundee.</gtr:impact><gtr:outcomeId>9C1A3BF4A8B</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cell Signalling Challenge Dundee Science Festival 2011</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>32FDB0AB-C018-4104-8C33-4A39D7706DF0</gtr:id><gtr:impact>Over 1000 people attended family fun days at the Dundee Science Festival, at which we organized an activity explaining type 1 and type 11 diabetes, and aspects of intracellular signalling.

Feedback sheets were completed by visitors, and will be analysed, in due course.</gtr:impact><gtr:outcomeId>A4ezGW5v1XA</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Doors Open Day College of Life Sciences, University of Dundee Sept 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>C67FCEC8-51E3-4B7C-8651-55A6573A5A01</gtr:id><gtr:impact>Our 'Cell Signalling Challenge' was completed by many visitors throughout the day, and we fielded many questions about diabetes from children, teenagers and adults.

A lot of interest, but specific impacts unknown.</gtr:impact><gtr:outcomeId>dGjVNMrrYqw</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh International Science Festival 2011</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>62F74E9E-922D-4F65-B731-0A14123A2ACC</gtr:id><gtr:impact>Several hundred school students attended workshop sessions over a 2-week period, and feedback was excellent.

Student demonstrators gained experience that prompted at least one of them to take part in more extensive school-based science activities.</gtr:impact><gtr:outcomeId>WH8gxfr5hqU</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Made of Molecules Tent at Tayport Summer Festival 2010</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>E7180E05-59B1-463C-9731-1D5938F9D56D</gtr:id><gtr:impact>I ran a 'Made of Molecules' tent for the Family Fun Day on the common of my home village of Tayport for the Summer Festival in July 2010, with three activities on the theme of Sugar and Diabetes. We were non-stop busy all day, and 70 people, aged from toddlers to 80-year-olds did all three of our activities.

We've been asked back next year. Also, asked to run Cafe Science activities in the village next year.</gtr:impact><gtr:outcomeId>PJcrBUT5ffY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Treaty of Windsor UK-Portugal travel and collaboration</gtr:description><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:id>D8D09192-554D-4D45-BCE3-CFE754766A7F</gtr:id><gtr:outcomeId>1E50954FF0B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dundee Cancer Centre Development Fund</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Dundee Cancer Centre Development Fund (DCC)</gtr:fundingOrg><gtr:id>1CBF4E40-1513-4DBF-9DE1-BEAB48E57C55</gtr:id><gtr:outcomeId>dwEQxoEmXSH</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>327000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway Funding Scheme (DPFS)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>AE7515A8-CB3F-4C33-BC0C-855DD384DD7B</gtr:id><gtr:outcomeId>21EB5865AE80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>173290</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:fundingRef>BDA 12/0004557</gtr:fundingRef><gtr:id>F8A3EC96-79A2-4C2F-B059-169E71686EC0</gtr:id><gtr:outcomeId>eYqx8hRLD54</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>149482</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, Project Grant</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>A1D83CD0-1408-41A2-A210-7BF02E4ADAE3</gtr:id><gtr:outcomeId>F8F61691F8A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biochemical Society Outreach Grant/Biochemical Society</gtr:description><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>E4F82F2B-2D6E-4829-977C-E69F4D41F887</gtr:id><gtr:outcomeId>c4hFto1cGpt0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>92071</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>The Cunningham Trust</gtr:department><gtr:description>Cunningham Trust, Project Grant</gtr:description><gtr:end>2007-12-02</gtr:end><gtr:fundingOrg>University of St Andrews</gtr:fundingOrg><gtr:id>DAB02534-DF2D-4D60-87E1-36414A645C5E</gtr:id><gtr:outcomeId>33526D680300</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UNESCO Centre for Water Law, Policy and Science</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5DFDBF07-9769-4305-83BF-B64F07E5BDF2</gtr:id><gtr:impact>Contributed to establishment of the Dundee Centre for Water Law, Policy and Science, University of Dundee, under the auspices of UNESCO. Gave opportunities for me to highlight scientific findings on the freshwater cyanobacterial toxin microcystin, which inhibits protein phosphatases, and for me to learn about the water industry and policy making related to water supplies.</gtr:impact><gtr:outcomeId>6F827F7024A</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A database with graphic interface that details 14-3-3-binding sites, other phosphorylated sites and pfam domains on target proteins</gtr:description><gtr:id>F8DE8FA6-FD93-47E8-BAFB-F6160BE4D9F1</gtr:id><gtr:impact>Expect this database to be useful to the wider research community, and also facilitate our in-house analyses.</gtr:impact><gtr:outcomeId>1D596DDBDD3</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Database of 14-3-3-binding sites</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>81A2D8EB-A9A7-428C-ABB2-DE7703915F25</gtr:id><gtr:title>Mechanism of activation of PKB/Akt by the protein phosphatase inhibitor Calyculin A.</gtr:title><gtr:parentPublicationTitle>Cell biochemistry and biophysics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/585617eaa3947795ff0812199452f105"><gtr:id>585617eaa3947795ff0812199452f105</gtr:id><gtr:otherNames>Pozuelo-Rubio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1085-9195</gtr:issn><gtr:outcomeId>d3AagWeykpi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03F031F2-C704-461A-8E48-9AD63810EF63</gtr:id><gtr:title>Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1661961c3e118f7f4e3b8856f64cecee"><gtr:id>1661961c3e118f7f4e3b8856f64cecee</gtr:id><gtr:otherNames>Chen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>D488B1C064A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>305F29A8-8BDE-4028-847A-34FB12DEA09D</gtr:id><gtr:title>Thr649Ala-AS160 knock-in mutation does not impair contraction/AICAR-induced glucose transport in mouse muscle.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68f28f915d2d3fdbe71edc6b29469ea3"><gtr:id>68f28f915d2d3fdbe71edc6b29469ea3</gtr:id><gtr:otherNames>Ducommun S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>pm_12911_21_22318952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D112ACC-00C9-49C6-B2C0-EBCD2E86F6BB</gtr:id><gtr:title>Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce50e72dc241add1ab921135c6b14ce5"><gtr:id>ce50e72dc241add1ab921135c6b14ce5</gtr:id><gtr:otherNames>Geraghty KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>4776A604ED7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08DD013B-3AFC-40C4-B4FB-C3F9F657D5CE</gtr:id><gtr:title>Phosphorylation and 14-3-3 binding of Arabidopsis trehalose-phosphate synthase 5 in response to 2-deoxyglucose.</gtr:title><gtr:parentPublicationTitle>The Plant journal : for cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1c3374b8ebc90c4522d9ccff88ecce"><gtr:id>1d1c3374b8ebc90c4522d9ccff88ecce</gtr:id><gtr:otherNames>Harthill JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0960-7412</gtr:issn><gtr:outcomeId>049FB0B8F62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6085BABB-23EC-451F-A71C-EB51275C5F65</gtr:id><gtr:title>PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4633d5ac5bb1e53876086fc5c32455f"><gtr:id>a4633d5ac5bb1e53876086fc5c32455f</gtr:id><gtr:otherNames>Fonseca BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>F66AED6AA43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F00C799-0008-4D85-96DD-E8D7734BA4BA</gtr:id><gtr:title>Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdf1a0ee43581f510be4559dfd6ba0d2"><gtr:id>bdf1a0ee43581f510be4559dfd6ba0d2</gtr:id><gtr:otherNames>Hunter RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>B7EDFC82375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CEB5477-FA17-4714-B987-C560D6C17C5D</gtr:id><gtr:title>ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capic&amp;uacute;a.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2c557cf490ecbc198c7e15be7292548"><gtr:id>d2c557cf490ecbc198c7e15be7292548</gtr:id><gtr:otherNames>Dissanayake K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>KTTVUtBQkpG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E73DC0D-1DAE-4066-A557-750EC9151A1F</gtr:id><gtr:title>Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5eb382ed38a9d892555866940140aec5"><gtr:id>5eb382ed38a9d892555866940140aec5</gtr:id><gtr:otherNames>Pehm?ller C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>5FA1DF4A213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53D8921B-B19F-40AF-9027-DFFEF30DD31D</gtr:id><gtr:title>Evolution of signal multiplexing by 14-3-3-binding 2R-ohnologue protein families in the vertebrates.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73fd76af87560d58b16e34f6a116a4b7"><gtr:id>73fd76af87560d58b16e34f6a116a4b7</gtr:id><gtr:otherNames>Tinti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_12911_21_22870394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A34C561C-E699-4228-B12F-8FCAD6310F2A</gtr:id><gtr:title>Identification of the amino acids 300-600 of IRS-2 as 14-3-3 binding region with the importance of IGF-1/insulin-regulated phosphorylation of Ser-573.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e49e0bf9925917e1614eb7ad3c09951"><gtr:id>3e49e0bf9925917e1614eb7ad3c09951</gtr:id><gtr:otherNames>Neukamm SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12911_21_22912850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95F483F6-D1DF-4A9D-AEF2-98A15903D40B</gtr:id><gtr:title>14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2--Potential interplay with the PKB/Akt pathway and p14(ARF).</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e9241dec37f5d184cd02fc49901a087"><gtr:id>5e9241dec37f5d184cd02fc49901a087</gtr:id><gtr:otherNames>Wood NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>AA8C86F86C6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21793CCD-36D6-42D5-8BB6-56C8C3CC9255</gtr:id><gtr:title>The capture of phosphoproteins by 14-3-3 proteins mediates actions of insulin.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1661961c3e118f7f4e3b8856f64cecee"><gtr:id>1661961c3e118f7f4e3b8856f64cecee</gtr:id><gtr:otherNames>Chen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>f3BYBsBMnSA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>565DDC76-7C8A-4D2F-A871-420E03BE6BA0</gtr:id><gtr:title>Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes.</gtr:title><gtr:parentPublicationTitle>Cellular signalling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1661961c3e118f7f4e3b8856f64cecee"><gtr:id>1661961c3e118f7f4e3b8856f64cecee</gtr:id><gtr:otherNames>Chen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0898-6568</gtr:issn><gtr:outcomeId>A5BDC33EFFB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C85D08CA-4125-4554-B5F7-05493C2B3502</gtr:id><gtr:title>Proteomic screen in the simple metazoan Hydra identifies 14-3-3 binding proteins implicated in cellular metabolism, cytoskeletal organisation and Ca2+ signalling.</gtr:title><gtr:parentPublicationTitle>BMC cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0264f1c89b8ca251656b4c57483c7ec3"><gtr:id>0264f1c89b8ca251656b4c57483c7ec3</gtr:id><gtr:otherNames>Pauly B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2121</gtr:issn><gtr:outcomeId>167DF2EB3F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3442506C-5EF4-455B-9552-67ADD9169A2E</gtr:id><gtr:title>ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d21ad7f4b34468a363874abc6405548"><gtr:id>3d21ad7f4b34468a363874abc6405548</gtr:id><gtr:otherNames>Hoxhaj G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_12911_21_22797923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>289B806E-832C-4CF5-8963-1B3661CD4E69</gtr:id><gtr:title>Potential role of TBC1D4 in enhanced post-exercise insulin action in human skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0ef46672e23a640bf77ca70e096bd95"><gtr:id>a0ef46672e23a640bf77ca70e096bd95</gtr:id><gtr:otherNames>Treebak JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>01A203D707F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7373EC21-C798-4FED-B0D4-8AB53E7E11EF</gtr:id><gtr:title>AS160 deficiency causes whole-body insulin resistance via composite effects in multiple tissues.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f79e95f87a134bc2b9e9ab4857233a20"><gtr:id>f79e95f87a134bc2b9e9ab4857233a20</gtr:id><gtr:otherNames>Wang HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_12911_21_23078342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2510E1D-3292-4921-8736-4ABFB771B9AC</gtr:id><gtr:title>Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1661961c3e118f7f4e3b8856f64cecee"><gtr:id>1661961c3e118f7f4e3b8856f64cecee</gtr:id><gtr:otherNames>Chen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>rnyJwefXnCC</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127084354</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>